1. Economic family burden of metabolic control in children and adolescents with type 1 diabetes mellitus.
- Author
-
Altamirano-Bustamante N, Islas-Ortega L, Robles-Valdés C, Garduño-Espinosa J, Morales-Cisneros G, Valderrama A, Calzada-León R, Cuevas ML, Xancopinca JL, and Altamirano-Bustamante MM
- Subjects
- Adolescent, Blood Glucose metabolism, Blood Glucose Self-Monitoring economics, Child, Data Collection, Diabetes Mellitus, Type 1 metabolism, Female, Humans, Insulin blood, Male, Mexico, Cost of Illness, Diabetes Mellitus, Type 1 drug therapy, Diabetes Mellitus, Type 1 economics, Family, Health Care Costs statistics & numerical data
- Abstract
Aim: To appraise the economic burden for families of patients with type 1 diabetes mellitus (DM1) at the Instituto Nacional de Pediatria in Mexico City., Patients and Methods: DM1 family direct costs were obtained from a standardized economic survey in 59 children with no chronic severe complications such as kidney failure in 2002-3., Results: Mean family annual direct cost of treatment and monitoring was US $1689.87 which includes government funding given to both outpatients and inpatients. Despite this, DM1 out-of-pocket cost for families is very high compared to the minimum official wage of approximately $4.00 dollar/day versus $4.06 cost DM1/day. No correlation between parents' age, education or socio-economic level and direct cost was statistically significant., Conclusions: The highest economic burden was due to self-monitoring of blood glucose (SMBG) 53.0% and insulin 14.8%. The costs were higher in children with poor metabolic control who performed SMBG less often.
- Published
- 2008
- Full Text
- View/download PDF